{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:29:47Z","timestamp":1793694587277,"version":"4.5.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["R\\u20133-0005"],"award-info":[{"award-number":["R\\u20133-0005"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phrs.2026.108476","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:16:29Z","timestamp":1790698589000},"page":"108476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MT-Exo-derived miR-4651 and miR-6126 coordinately regulate the SRSF1\u2013progerin and SP1\u2013PrP\u1d9c axes to attenuate vascular aging in HGPS"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5972-6191","authenticated-orcid":false,"given":"Eun Young","family":"Joo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unyoung","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hee","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Shin","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Sun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Seob","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwang-Seong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6713-8229","authenticated-orcid":false,"given":"Sang Hun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108476_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson\u2013Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108476_bib2","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/ATVBAHA.110.209460","article-title":"Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging","volume":"30","author":"Olive","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2026.108476_bib3","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.2018.3264","article-title":"Association of lonafarnib treatment vs no treatment with mortality rate in patients with Hutchinson-Gilford progeria syndrome","volume":"319","author":"Gordon","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2026.108476_bib4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41591-021-01262-4","article-title":"Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson\u2013Gilford progeria syndrome","volume":"27","author":"Puttaraju","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.108476_bib5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41591-021-01274-0","article-title":"A targeted antisense therapeutic approach for Hutchinson\u2013Gilford progeria syndrome","volume":"27","author":"Erdos","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.108476_bib6","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1016\/j.ymthe.2025.06.017","article-title":"Precise progerin targeting using RfxCas13d: a therapeutic avenue for Hutchinson-Gilford progeria syndrome","volume":"33","author":"Chae","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2026.108476_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12915-017-0375-5","article-title":"The biological function of the cellular prion protein: an update","volume":"15","author":"Wulf","year":"2017","journal-title":"BMC Biol."},{"key":"10.1016\/j.phrs.2026.108476_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12632","article-title":"Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem\/stromal cells via cellular prion proteins","volume":"68","author":"Yoon","year":"2020","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.phrs.2026.108476_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/20417314211059624","article-title":"Exosomes isolated from melatonin-stimulated mesenchymal stem cells improve kidney function by regulating inflammation and fibrosis in a chronic kidney disease mouse model","volume":"12","author":"Yea","year":"2021","journal-title":"J. Tissue Eng."},{"key":"10.1016\/j.phrs.2026.108476_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgaf123","article-title":"The future of in silico trials and digital twins in medicine","volume":"4","author":"Samei","year":"2025","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.phrs.2026.108476_bib11","article-title":"Digital twins, synthetic patient data, and in-silico trials: can they empower paediatric clinical trials?","volume":"7","author":"Pammi","year":"2025","journal-title":"Lancet Digit. Health"},{"key":"10.1016\/j.phrs.2026.108476_bib12","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.82728","article-title":"Lonafarnib improves cardiovascular function and survival in a mouse model of Hutchinson-Gilford progeria syndrome","volume":"12","author":"Murtada","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.phrs.2026.108476_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2022.11.003","article-title":"FDA approval summary for lonafarnib (Zokinvy) for the treatment of Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies","volume":"25","author":"Suzuki","year":"2023","journal-title":"Genet. Med."},{"key":"10.1016\/j.phrs.2026.108476_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00418-016-1411-1","article-title":"Molecular insights into the premature aging disease progeria","volume":"145","author":"Vidak","year":"2016","journal-title":"Histochem. Cell. Biol."},{"key":"10.1016\/j.phrs.2026.108476_bib15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1172\/JCI121297","article-title":"Endothelial progerin expression causes cardiovascular pathology through an impaired mechanoresponse","volume":"129","author":"Osmanagic-Myers","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2026.108476_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeac047","article-title":"Vascular senescence in progeria: role of endothelial dysfunction","volume":"2","author":"Xu","year":"2022","journal-title":"Eur. Heart J. Open."},{"key":"10.1016\/j.phrs.2026.108476_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.molmed.2024.12.008","article-title":"Vascular dysfunction in Hutchinson\u2013Gilford progeria syndrome","volume":"31","author":"Zhao","year":"2025","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.phrs.2026.108476_bib18","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1038\/s41467-019-13018-3","article-title":"Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson\u2013Gilford progeria syndrome","volume":"10","author":"Aguado","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108476_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.156","article-title":"Mesenchymal stem cell-derived extracellular vesicles: recent therapeutics and targeted drug delivery advances","volume":"3","author":"Bhat","year":"2024","journal-title":"J. Extracell. Biol."},{"key":"10.1016\/j.phrs.2026.108476_bib20","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.ymthe.2024.02.025","article-title":"Therapeutic potential of RNA-enriched extracellular vesicles: the next generation in RNA delivery via biogenic nanoparticles","volume":"32","author":"Muskan","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2026.108476_bib21","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1021\/acs.nanolett.1c00094","article-title":"Natural or synthetic RNA delivery: a stoichiometric comparison of extracellular vesicles and synthetic nanoparticles","volume":"21","author":"Murphy","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.phrs.2026.108476_bib22","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/sctm.18-0226","article-title":"Mesenchymal stem cell-derived extracellular vesicles as therapeutics and as a drug delivery platform","volume":"8","author":"Baek","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.phrs.2026.108476_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.20517\/evcna.2025.33","article-title":"Extracellular vesicles as vehicles for small non-coding RNA therapeutics: standardization challenges for clinical translation","volume":"6","author":"Luisotti","year":"2025","journal-title":"Extracell. Vesicles Circ. Nucl. Acids"},{"key":"10.1016\/j.phrs.2026.108476_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fmolb.2017.00019","article-title":"Physiological functions of the cellular prion protein","volume":"4","author":"Castle","year":"2017","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.phrs.2026.108476_bib25","first-page":"8042","article-title":"Cellular prion protein (PrPC) and its role in stress responses","volume":"8","author":"Zeng","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.phrs.2026.108476_bib26","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1093\/hmg\/ddr385","article-title":"A conserved splicing mechanism of the LMNA gene controls premature aging","volume":"20","author":"Lopez-Mejia","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2026.108476_bib27","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1172\/JCI85908","article-title":"Modulation of LMNA splicing as a strategy to treat prelamin A diseases","volume":"126","author":"Lee","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2026.108476_bib28","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1158\/1541-7786.MCR-14-0131","article-title":"Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer","volume":"12","author":"Das","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.phrs.2026.108476_bib29","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/ajmg.a.31346","article-title":"Hutchinson\u2013Gilford progeria syndrome: review of the phenotype","volume":"140","author":"Hennekam","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.phrs.2026.108476_bib30","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJMoa0706898","article-title":"Phenotype and course of Hutchinson\u2013Gilford progeria syndrome","volume":"358","author":"Merideth","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108476_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41746-024-01073-0","article-title":"Digital twins for health: a scoping review","volume":"7","author":"Katsoulakis","year":"2024","journal-title":"NPJ Digit. Med."},{"key":"10.1016\/j.phrs.2026.108476_bib32","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1038\/s41467-021-23998-w","article-title":"In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials","volume":"12","author":"Sarrami-Foroushani","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108476_bib33","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/bib\/bby043","article-title":"silico clinical trials: concepts and early adoptions","volume":"20","author":"Pappalardo","year":"2019","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.phrs.2026.108476_bib34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41746-025-02068-1","article-title":"Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies","volume":"8","author":"Pistollato","year":"2025","journal-title":"npj Digit. Med."},{"key":"10.1016\/j.phrs.2026.108476_bib35","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11095-024-03757-4","article-title":"Quality and safety considerations for therapeutic products based on extracellular vesicles","volume":"41","author":"Takakura","year":"2024","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2026.108476_bib36","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.2147\/IJN.S502591","article-title":"Extracellular vesicles: a review of their therapeutic potentials, sources, biodistribution, and administration routes","volume":"20","author":"Su","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.phrs.2026.108476_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12085","article-title":"Biodistribution of extracellular vesicles following administration into animals: a systematic review","volume":"10","author":"Kang","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.phrs.2026.108476_bib38","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/ijms21020665","article-title":"Advances in analysis of biodistribution of exosomes by molecular imaging","volume":"21","author":"Yi","year":"2020","journal-title":"Int. J. Mol. Sci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:01:15Z","timestamp":1793692875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826003919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"alternative-id":["S1043661826003919"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108476","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MT-Exo-derived miR-4651 and miR-6126 coordinately regulate the SRSF1\u2013progerin and SP1\u2013PrP\u1d9c axes to attenuate vascular aging in HGPS","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108476"}}